CONMED (CNMD) - Stock Price & Dividends
Exchange: USA Stocks • Country: United States • Currency: USD • Type: Common Stock • ISIN: US2074101013
CONMED Corporation, listed as CNMD on the NYSE, is a prominent medical technology company that focuses on developing, manufacturing, and distributing a wide range of surgical devices and related equipment for surgeries worldwide. They take pride in providing unique clinical solutions that cater specifically to orthopedic surgeons, aiding in the repair of soft tissue injuries, particularly for minimally invasive sports medicine surgeries.
Under various brands like Hall, CONMED Linvatec, Concept, and Shutt, CONMED offers orthopedic surgery products like TruShot with Y-Knot All-In-One Soft Tissue Fixation System, Y-knot All-Suture Anchors, and Agro Knotless Suture Anchors.
In addition to orthopedic surgery products, CONMED also handles general surgery products such as clinical insufflation, smoke evacuation, electrosurgical, and endomechanical products, providing a comprehensive suite of solutions for different surgical needs.
Furthermore, CONMED's endoscopic technologies extend to therapeutic and diagnostic products for gastroenterology procedures, and treatments relating to dilatation, hemostasis, biliary diseases, structure management, and infection prevention. They also offer patient monitoring solutions including ECG and EEG electrodes, along with cardiac defibrillation pads.
Beyond product development, CONMED markets its offerings directly to healthcare institutions like hospitals, surgery centers, and other medical facilities, as well as through specialized medical distributors, ensuring widespread accessibility to their innovative solutions. Founded in 1970, CONMED Corporation is headquartered in Largo, Florida, and their official website is https://www.conmed.com.
Drawdown (Underwater) Chart
Overall Trend and Yearly Seasonality
CNMD Stock Overview
Market Cap in USD | 2,237m |
Sector | Healthcare |
Industry | Medical Devices |
GiC SubIndustry | Health Care Equipment |
TER | 0.00% |
IPO / Inception | 1987-07-23 |
CNMD Stock Ratings
Growth 5y | -1.35 |
Fundamental | 9.00 |
Dividend | 5.19 |
Rel. Performance vs Sector | -6.12 |
Analysts | 3.75/5 |
Fair Price Momentum | 52.39 USD |
Fair Price DCF | 96.56 USD |
CNMD Dividends
Yield 12m | 1.29% |
Yield on Cost 5y | 1.06% |
Dividends CAGR 5y | 0.00% |
Payout Consistency | 97.9% |
CNMD Growth Ratios
Growth 12m | -51.35% |
Growth Correlation 12m | -65% |
Growth Correlation 3m | -62% |
CAGR 5y | -3.92% |
Sharpe Ratio 12m | -1.57 |
Alpha vs SP500 12m | -86.45 |
Beta vs SP500 5y weekly | 1.60 |
ValueRay RSI | 4.44 |
Volatility GJR Garch 1y | 46.53% |
Price / SMA 50 | -21.05% |
Price / SMA 200 | -37.31% |
Current Volume | 2611.5k |
Average Volume 20d | 593.9k |
External Links for CNMD Stock
Wall Street Journal • Benzinga • Yahoo Finance
Tweets
X (Twitter) • Stocktwits
Fund Manager Positions
Dataroma • Stockcircle
As of April 27, 2024, the stock is trading at USD 61.90 with a total of 2,611,493 shares traded.
Over the past week, the price has changed by -12.92%, over one month by -19.25%, over three months by -33.84% and over the past year by -45.88%.
According to ValueRays Forecast Model, CNMD CONMED will be worth about 57.9 in April 2025. The stock is currently trading at 61.90. This means that the stock has a potential downside of -6.4%.
Issuer | Forecast | Upside |
---|---|---|
Wallstreet Target Price | 110.6 | 78.6 |
Analysts Target Price | 135.1 | 118 |
ValueRay Target Price | 57.9 | -6.40 |